NO903513L - Fremgangsmaate for fremstilling av cykliske neurokinin a-antagonister. - Google Patents

Fremgangsmaate for fremstilling av cykliske neurokinin a-antagonister.

Info

Publication number
NO903513L
NO903513L NO90903513A NO903513A NO903513L NO 903513 L NO903513 L NO 903513L NO 90903513 A NO90903513 A NO 90903513A NO 903513 A NO903513 A NO 903513A NO 903513 L NO903513 L NO 903513L
Authority
NO
Norway
Prior art keywords
cycleic
neurokinin
antagonists
procedure
preparation
Prior art date
Application number
NO90903513A
Other languages
English (en)
Other versions
NO177715B (no
NO177715C (no
NO903513D0 (no
Inventor
Scott Lee Harbeson
Stephen Hendersen Buck
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of NO903513D0 publication Critical patent/NO903513D0/no
Publication of NO903513L publication Critical patent/NO903513L/no
Publication of NO177715B publication Critical patent/NO177715B/no
Publication of NO177715C publication Critical patent/NO177715C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/22—Tachykinins, e.g. Eledoisins, Substance P; Related peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Oncology (AREA)
  • Urology & Nephrology (AREA)
  • Transplantation (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Rheumatology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO903513A 1989-08-10 1990-08-09 Analogifremgangsmåte for fremstilling av cykliske neurokinin A-antagonister NO177715C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US39223689A 1989-08-10 1989-08-10

Publications (4)

Publication Number Publication Date
NO903513D0 NO903513D0 (no) 1990-08-09
NO903513L true NO903513L (no) 1991-02-11
NO177715B NO177715B (no) 1995-07-31
NO177715C NO177715C (no) 1995-11-08

Family

ID=23549831

Family Applications (1)

Application Number Title Priority Date Filing Date
NO903513A NO177715C (no) 1989-08-10 1990-08-09 Analogifremgangsmåte for fremstilling av cykliske neurokinin A-antagonister

Country Status (22)

Country Link
US (1) US5731286A (no)
EP (1) EP0412542B1 (no)
JP (1) JP2829779B2 (no)
KR (1) KR0169123B1 (no)
CN (1) CN1035056C (no)
AR (1) AR246087A1 (no)
AT (1) ATE132503T1 (no)
AU (1) AU638264B2 (no)
CA (1) CA2022740C (no)
DD (1) DD297168A5 (no)
DE (1) DE69024555T2 (no)
DK (1) DK0412542T3 (no)
ES (1) ES2084627T3 (no)
FI (1) FI95913C (no)
GR (1) GR3018984T3 (no)
HU (1) HU206729B (no)
IE (1) IE69382B1 (no)
IL (1) IL95309A (no)
NO (1) NO177715C (no)
NZ (1) NZ234814A (no)
PT (1) PT94952B (no)
ZA (1) ZA906188B (no)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ229552A (en) * 1988-06-20 1992-06-25 Merrell Dow Pharma Neurokinin a antagonists
DE4034829A1 (de) * 1990-11-02 1992-05-07 Merck Patent Gmbh Cyclopeptide
FR2676055B1 (fr) * 1991-05-03 1993-09-03 Sanofi Elf Composes polycycliques amines et leurs enantiomeres, procede pour leur preparation et compositions pharmaceutiques les contenant.
US5625060A (en) * 1991-05-03 1997-04-29 Elf Sanofi Polycyclic amine compounds and their enantiomers, their method of preparation and pharmaceutical compositions on which they are present
JPH06509571A (ja) * 1991-08-08 1994-10-27 エイ・メナリニ・インダストリー・ファーマシューティケ・リウニテ・エスアールエル タキキニン拮抗薬としての環状ヘキサペプチドの製法およびその薬学的化合物
US5731285A (en) * 1992-04-15 1998-03-24 A. Menatini Industrie Farmaceutiche Tachiquinine antagonist tricyclic compounds, preparation of same and pharmaceutical compositions containing such compounds
ES2634431T3 (es) 2009-03-16 2017-09-27 The Governing Council Of The University Of Toronto Moléculas de aminoácidos cíclicos y procedimientos de preparación de las mismas
KR20180095809A (ko) 2015-11-11 2018-08-28 인사이클 세라퓨틱스, 인코포레이티드 α4β7 인테그린을 표적으로 하는 고리형 펩타이드
WO2018085921A1 (en) 2016-11-11 2018-05-17 Encycle Therapeutics, Inc. CYCLIC PEPTIDES MULTIMERS TARGETING α4β7 INTEGRIN
IL270465B (en) 2017-05-10 2022-09-01 Encycle Therapeutics Inc Cyclic peptides targeting alpha4beta7 integrin

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4742156A (en) * 1985-09-30 1988-05-03 Mcneilab, Inc. Peptide antagonists of neurokinin B and opthalmic solutions containing them
US4665157A (en) * 1985-09-30 1987-05-12 Mcneilab, Inc. Peptide antagonists of neurokinin B
DE3711335A1 (de) * 1987-04-03 1988-10-20 Merck Patent Gmbh Aminosaeurederivate
GB8807246D0 (en) * 1988-03-25 1988-04-27 Merck Sharp & Dohme Therapeutic agents
NZ229552A (en) * 1988-06-20 1992-06-25 Merrell Dow Pharma Neurokinin a antagonists
IE903957A1 (en) * 1989-11-06 1991-05-08 Sanofi Sa Aromatic amine compounds, their method of preparation and¹pharmaceutical compositions in which they are present
IL99320A (en) * 1990-09-05 1995-07-31 Sanofi Sa Arylalkylamines, their preparation and pharmaceutical preparations containing them
FR2677361A1 (fr) * 1991-06-04 1992-12-11 Adir Nouveaux peptides et pseudopeptides, derives de tachykinines, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.

Also Published As

Publication number Publication date
AR246087A1 (es) 1994-03-30
EP0412542A2 (en) 1991-02-13
ES2084627T3 (es) 1996-05-16
DE69024555T2 (de) 1996-05-15
IE69382B1 (en) 1996-09-04
CA2022740C (en) 2000-05-02
NO177715B (no) 1995-07-31
DD297168A5 (de) 1992-01-02
CN1049353A (zh) 1991-02-20
FI95913B (fi) 1995-12-29
AU638264B2 (en) 1993-06-24
IL95309A (en) 1995-07-31
HU904952D0 (en) 1991-01-28
FI95913C (fi) 1996-04-10
JP2829779B2 (ja) 1998-12-02
IE902886A1 (en) 1991-02-27
ZA906188B (en) 1991-06-26
ATE132503T1 (de) 1996-01-15
PT94952A (pt) 1991-04-18
US5731286A (en) 1998-03-24
GR3018984T3 (en) 1996-05-31
AU6022290A (en) 1991-05-16
HU206729B (en) 1992-12-28
KR0169123B1 (ko) 1999-01-15
CA2022740A1 (en) 1991-02-11
JPH03141295A (ja) 1991-06-17
NO177715C (no) 1995-11-08
EP0412542A3 (en) 1991-07-24
KR910004665A (ko) 1991-03-29
EP0412542B1 (en) 1996-01-03
HUT54713A (en) 1991-03-28
DK0412542T3 (da) 1996-01-29
FI903922A0 (fi) 1990-08-08
DE69024555D1 (de) 1996-02-15
NZ234814A (en) 1992-03-26
PT94952B (pt) 1997-07-31
IL95309A0 (en) 1991-06-30
CN1035056C (zh) 1997-06-04
NO903513D0 (no) 1990-08-09

Similar Documents

Publication Publication Date Title
NO900830D0 (no) Fremgangsmaate for fremstilling av piperidinforbindelser.
NO890269D0 (no) Fremgangsmaate for fremstilling av 1,4-disubstituerte-piperidinyl-forbindelser.
NO902003D0 (no) Fremgangsmaate for fremstilling av n-heteroaryl-4-quinolinaminer.
NO900774D0 (no) Fremgangsmaate for fremstilling av polyamider.
NO901554D0 (no) Fremgangsmaate for fremstilling av dinatrium-cefodizim.
NO904059L (no) Fremgangsmaate for fremstilling av nye substituerte isokinoliner.
NO904285D0 (no) Fremgangsmaate for fremstilling av substituerte karboksytetrahydroisokinoliner.
NO903513L (no) Fremgangsmaate for fremstilling av cykliske neurokinin a-antagonister.
NO901391D0 (no) Fremgangsmaate for fremstilling av et 1,8-naftyridin-derivat.
NO892542L (no) Fremgangsmaate for fremstilling av neurokinin a antagonister.
NO904069L (no) Fremgangsmaate for fremstilling av nye alkanofenoner.
NO901067L (no) Fremgangsmaate for fremstilling av tiofener.
NO903666D0 (no) Fremgangsmaate for fremstilling av pyrrolokinolinforbindelser.
NO904061L (no) Fremgangsmaate for fremstilling av nmda-antagonister.
NO904060L (no) Fremgangsmaate for fremstilling av substituerte dibenzofuraner.
NO900969L (no) Fremgangsmaate for fremstilling av n-allymetatrifluormetylanilin.
NO904535D0 (no) Fremgangsmaate for fremstilling av fenoxy-heterocykliske forbindelser.
NO880409D0 (no) Fremgangsmaate for fremstilling av 14,15-substituerte lanosteroler.
NO904070D0 (no) Fremgangsmaate for fremstilling av alkanfenoner.
NO901401D0 (no) Fremgangsmaate for fremstilling av nye 1-difenylmethylpiperidinderivater.
NO890538D0 (no) Fremgangsmaate for fremstilling av oxadiazolyl-azabicyclo-heptaner.
NO890539D0 (no) Fremgangsmaate for fremstilling av lipofile oxadiazoler.
NO920207D0 (no) Fremgangsmaate for fremstilling av 6-methyl-oestra-4,6-diener
ATE91413T1 (de) Hypotensiver wirkstoff.
FI894896A0 (fi) Anordning foer separering av aemnen fraon vatten.